Annual Accounts Receivable
N/A
31 December 2022
Summary:
Nymox Pharmaceutical annual accounts receivable is not available.NYMX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
31 March 2023
Summary:
Nymox Pharmaceutical quarterly accounts receivable is not available.NYMX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NYMX Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Nymox Pharmaceutical Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $1000.00(0.0%) |
| June 2020 | - | $1000.00(0.0%) |
| Mar 2020 | - | $1000.00(-75.0%) |
| Dec 2019 | $4000.00(+100.0%) | $4000.00(-42.9%) |
| Sept 2019 | - | $7000.00(-30.0%) |
| June 2019 | - | $10.00 K(0.0%) |
| Mar 2019 | - | $10.00 K(+400.0%) |
| Dec 2018 | $2000.00(-97.5%) | $2000.00(-77.8%) |
| Sept 2018 | - | $9000.00(-43.8%) |
| June 2018 | - | $16.00 K(+6.7%) |
| Mar 2018 | - | $15.00 K(-81.0%) |
| Dec 2017 | $79.00 K(+1216.7%) | $79.00 K(+6483.3%) |
| Sept 2017 | - | $1200.00(+50.0%) |
| June 2017 | - | $800.00(-94.6%) |
| Mar 2017 | - | $14.70 K(+145.0%) |
| Dec 2016 | $6000.00(+500.0%) | $6000.00(-62.5%) |
| Sept 2016 | - | $16.00 K(-44.3%) |
| June 2016 | - | $28.70 K(+769.7%) |
| Mar 2016 | - | $3300.00(+230.0%) |
| Dec 2015 | $1000.00(-92.3%) | $1000.00(-99.3%) |
| Sept 2015 | - | $138.70 K(+992.1%) |
| June 2015 | - | $12.70 K(-47.1%) |
| Mar 2015 | - | $24.00 K(+84.6%) |
| Dec 2014 | $13.00 K(-92.8%) | $13.00 K(-77.1%) |
| Sept 2014 | - | $56.80 K(+281.2%) |
| June 2014 | - | $14.90 K(+28.4%) |
| Mar 2014 | - | $11.60 K(-93.6%) |
| Dec 2013 | $181.60 K(+491.5%) | $181.60 K(+785.9%) |
| Sept 2013 | - | $20.50 K(-79.6%) |
| June 2013 | - | $100.30 K(+3.3%) |
| Mar 2013 | - | $97.10 K(+216.3%) |
| Dec 2012 | $30.70 K(-2.5%) | $30.70 K(+27.9%) |
| Sept 2012 | - | $24.00 K(-31.8%) |
| June 2012 | - | $35.20 K(+27.1%) |
| Mar 2012 | - | $27.70 K(-12.1%) |
| Dec 2011 | $31.50 K(+178.8%) | $31.50 K(-35.7%) |
| Sept 2011 | - | $49.00 K(+46.3%) |
| June 2011 | - | $33.50 K(+42.6%) |
| Mar 2011 | - | $23.50 K(+108.0%) |
| Dec 2010 | $11.30 K | $11.30 K(+1783.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $600.00(-97.8%) |
| June 2010 | - | $27.50 K(-44.9%) |
| Mar 2010 | - | $49.90 K(-24.8%) |
| Dec 2009 | $66.40 K(+75.2%) | $66.40 K(+90.8%) |
| Sept 2009 | - | $34.80 K(+66.5%) |
| June 2009 | - | $20.90 K(-36.3%) |
| Mar 2009 | - | $32.80 K(-13.5%) |
| Dec 2008 | $37.90 K(-37.3%) | $37.90 K(-20.4%) |
| Sept 2008 | - | $47.60 K(-13.9%) |
| June 2008 | - | $55.30 K(-20.2%) |
| Mar 2008 | - | $69.30 K(+14.7%) |
| Dec 2007 | $60.40 K(+30.5%) | $60.40 K(+9.0%) |
| Sept 2007 | - | $55.40 K(-11.4%) |
| June 2007 | - | $62.50 K(+10.4%) |
| Mar 2007 | - | $56.60 K(+22.2%) |
| Dec 2006 | $46.30 K(-26.2%) | $46.30 K(+34.6%) |
| Sept 2006 | - | $34.40 K(-51.2%) |
| June 2006 | - | $70.50 K(+77.6%) |
| Mar 2006 | - | $39.70 K(-36.7%) |
| Dec 2005 | $62.70 K(+22.0%) | $62.70 K(-4.9%) |
| Sept 2005 | - | $65.90 K(+20.5%) |
| June 2005 | - | $54.70 K(-27.7%) |
| Mar 2005 | - | $75.70 K(+47.3%) |
| Dec 2004 | $51.40 K(+86.9%) | $51.40 K(+2.4%) |
| Sept 2004 | - | $50.20 K(-29.5%) |
| June 2004 | - | $71.20 K(+125.3%) |
| Mar 2004 | - | $31.60 K(+14.9%) |
| Dec 2003 | $27.50 K(-72.9%) | $27.50 K(-26.1%) |
| Sept 2003 | - | $37.20 K(-17.5%) |
| June 2003 | - | $45.10 K(-42.5%) |
| Mar 2003 | - | $78.50 K(-22.6%) |
| Dec 2002 | $101.40 K(-17.2%) | $101.40 K(-9.1%) |
| Sept 2002 | - | $111.50 K(-35.8%) |
| June 2002 | - | $173.70 K(-29.2%) |
| Mar 2002 | - | $245.30 K(+100.2%) |
| Dec 2001 | $122.50 K(+20.7%) | $122.50 K(-44.0%) |
| Sept 2001 | - | $218.80 K(+29.7%) |
| June 2001 | - | $168.70 K(+44.8%) |
| Mar 2001 | - | $116.50 K(+14.8%) |
| Dec 2000 | $101.50 K(+136.0%) | $101.50 K(+136.0%) |
| Dec 1999 | $43.00 K | $43.00 K |
FAQ
- What is the all time high annual accounts receivable for Nymox Pharmaceutical?
- What is the all time high quarterly accounts receivable for Nymox Pharmaceutical?
What is the all time high annual accounts receivable for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual accounts receivable is $181.60 K
What is the all time high quarterly accounts receivable for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly accounts receivable is $245.30 K